Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 14, 2022 2:33 PM 3 min read

Dow Dips 375 Points; S&P 500 Down Over 2%

by Lisa Levin Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 375 points on Friday.

The Dow traded down 1.25% to 29,662.76 while the NASDAQ fell 2.68% to 10,363.83. The S&P 500 also fell, dropping, 2.10% to 3,592.94.

Also check this: Market Volatility Declines Following US Inflation Data


Leading and Lagging Sectors


Health care shares fell by just 0.7% on Friday. Leading the sector was strength from Reata Pharmaceuticals, Inc. (NASDAQ:RETA) and Zymeworks Inc. (NASDAQ:ZYME).


In trading on Friday, energy shares dipped by 3.5%.


Top Headline

 

JPMorgan Chase & Co. (NYSE:JPM) posted better-than-expected earnings for its third quarter on Friday.


JPMorgan Chase posted Q3 earnings of $3.12 per share, topping market expectations of $2.88 per share.

 

Equities Trading UP


Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shares shot up 16% to $29.01. Reata Pharmaceuticals said FDA does not plan to hold advisory committee meeting to discuss the NDA for Omaveloxolone for Friedreich's Ataxia.


Shares of Nutanix, Inc. (NASDAQ:NTNX) got a boost, shooting 23% to $26.00 following a WSJ report indicating the company is exploring a sale after receiving takeover interest.


IMARA Inc. (NASDAQ:IMRA) shares were also up, gaining 38% to $3.57 after the company, along with Enliven Therapeutics, announced a merger agreement to combine the two companies in an all-stock transaction.


Equities Trading DOWN

First Republic Bank (NYSE:FRC) shares tumbled 16% to $113.28 after the company reported mixed Q3 results.


Shares of Morgan Stanley (NYSE:MS) were down 5.5% to $74.99 after the company reported Q3 EPS and sales results down from last year.

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) was down, falling 57% to $0.32 after the company announced pricing of $2 million public offering of 4 million units at $0.50 per unit.


Also check out: Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday


Commodities

In commodity news, oil traded down 3.9% to $85.67, while gold traded down 1.6% at $1,649.80.


Silver traded down 4.1% to $18.145 on Friday while copper fell 0.9% to $3.4095.


Euro zone


European shares closed higher today. The eurozone’s STOXX 600 rose 0.56%, London’s FTSE 100 rose 0.12% while Spain’s IBEX 35 Index rose 0.46%. The German DAX climbed 0.67%, French CAC 40 rose 0.90% and Italy’s FTSE MIB Index gained 0.70%.

The annual inflation rate in Spain fell to 8.9% in September from 10.5% in the prior month, while annual inflation rate in France eased to 5.6% in September from 5.9% in the previous month. Wholesale prices in Germany rose by 19.9% year-over-year in September.

 

Economics


US retail trade came in unchanged for September, missing market estimates for a 0.2% rise.


Import prices in the US fell by 1.2% from a month ago in September, while export prices dropped 0.8% in September.


US business inventories increased 0.8% from a month ago in September.


The University of Michigan consumer sentiment climbed to 59.8 in September, recording the highest level in six months, compared to 58.6 in the prior month.


The total number of active U.S. oil rigs climbed by 8 to 610 rigs this week, Baker Hughes Inc reported.

Check out this: Investor Fear Eases Slightly As Dow Jumps Over 800 Points


COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 98,779,940 cases with around 1,089,910 deaths. India confirmed a total of at least 44,623,990 cases and 528,850 deaths, while France reported over 36,102,540 COVID-19 cases with 155,730 deaths. In total, there were at least 629,035,400 cases of COVID-19 worldwide with more than 6,568,520 deaths.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Afternoon Market Update
IMRA Logo
IMRABitwise MARA Option Income Strategy ETF
$14.341.42%
Overview
JPM Logo
JPMJPMorgan Chase & Co
$282.970.03%
MS Logo
MSMorgan Stanley
$154.00-0.24%
NTNX Logo
NTNXNutanix Inc
$39.00-0.33%
NVOS Logo
NVOSNovo Integrated Sciences Inc
$0.00310-97.9%
ZYME Logo
ZYMEZymeworks Inc
$23.23-%
IMRA Logo
IMRABitwise MARA Option Income Strategy ETF
$14.341.42%
Overview
JPM Logo
JPMJPMorgan Chase & Co
$282.970.03%
MS Logo
MSMorgan Stanley
$154.00-0.24%
NTNX Logo
NTNXNutanix Inc
$39.00-0.33%
NVOS Logo
NVOSNovo Integrated Sciences Inc
$0.00310-97.9%
ZYME Logo
ZYMEZymeworks Inc
$23.23-%
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...